Miltenyi Biotec

Bergisch Gladbach, Germany Founded: 1989 • Age: 37 yrs
Develops tools and products for research and clinical application
Request Access

About Miltenyi Biotec

Miltenyi Biotec is a company based in Bergisch Gladbach (Germany) founded in 1989 by Stefan Miltenyi.. The company has 585 employees as of December 31, 2020. Miltenyi Biotec has completed 3 acquisitions, including LaVision BioTec, Lentigen and lino Biotech. Miltenyi Biotec operates in a competitive market with competitors including Abcam, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.

  • Headquarter Bergisch Gladbach, Germany
  • Employees 585 as on 31 Dec, 2020
  • Founders Stefan Miltenyi
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $304.41 K (USD), Grant

    Mar 01, 2021

  • Investors
    HHS

    & 1 more

  • Employee Count
    585

    as on Dec 31, 2020

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Miltenyi Biotec

  • Total Funding
  • Total Rounds 18
  • Last Round Grant — $304,414
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2021 Amount Grant - Miltenyi Biotec Valuation

investors

Jan, 2021 Amount Grant - Miltenyi Biotec Valuation

investors

Jan, 2020 Amount Grant - Miltenyi Biotec Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Miltenyi Biotec

Miltenyi Biotec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Miltenyi Biotec

Miltenyi Biotec has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include LaVision BioTec, Lentigen and lino Biotech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Molecular interactions in biological samples are measured via focal molography.
2020
Lentiviral vectors are developed for pre-clinical and clinical applications.
2004
Microscopes for cell analysis and preclinical imaging are developed.
2000
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Miltenyi Biotec

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Miltenyi Biotec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Miltenyi Biotec

Miltenyi Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
Dental implants and regenerative dentistry products are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Miltenyi Biotec

Frequently Asked Questions about Miltenyi Biotec

When was Miltenyi Biotec founded?

Miltenyi Biotec was founded in 1989 and raised its 1st funding round 21 years after it was founded.

Where is Miltenyi Biotec located?

Miltenyi Biotec is headquartered in Bergisch Gladbach, Germany. It is registered at Bergisch Gladbach, North Rhine-westphalia, Germany.

Who is the current CEO of Miltenyi Biotec?

Boris Stoffel is the current CEO of Miltenyi Biotec.

How many employees does Miltenyi Biotec have?

As of Dec 31, 2020, the latest employee count at Miltenyi Biotec is 585.

What does Miltenyi Biotec do?

Founded in 1989 and headquartered in Bergisch Gladbach, Germany, the company operates in the biomedical research and cellular therapy sector. Products are provided for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical applications, and imaging. Expertise is maintained in immunology, stem cell biology, neuroscience, cancer research, hematology, graft engineering, and apheresis.

Who are the top competitors of Miltenyi Biotec?

Miltenyi Biotec's top competitors include Abcam, Sutro Biopharma and Avidity Biosciences.

How many acquisitions has Miltenyi Biotec made?

Miltenyi Biotec has made 3 acquisitions, including LaVision BioTec, Lentigen, and lino Biotech.

Who are Miltenyi Biotec's investors?

Miltenyi Biotec has 2 investors. Key investors include HHS, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available